Shopping Cart
- Remove All
- Your shopping cart is currently empty
N,N'-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) is a carcinogen that targets the nasopharyngeal epithelium to promote nasopharyngeal carcinoma (NPC) metastasis by modulating various signaling pathways through protein phosphorylation, notably phosphorylating LYRIC at serine 568 [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | N,N'-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) is a carcinogen that targets the nasopharyngeal epithelium to promote nasopharyngeal carcinoma (NPC) metastasis by modulating various signaling pathways through protein phosphorylation, notably phosphorylating LYRIC at serine 568 [1]. |
In vitro | N,N'-Dinitrosopiperazine (referred to herein as 0.) exhibits specific activity within chemical processes by engaging in reactions characteristic to its molecular structure. |
In vivo | N,N'-Dinitrosopiperazine (administered via tail vein injection; 40 mg/kg; 30 days) suppresses cell motility and invasion while promoting nasopharyngeal carcinoma (NPC) metastasis in vivo. Immunohistochemistry (IHC) reveals that phospho-LYRIC levels are elevated in the metastatic tumors of DNP-treated mice compared to untreated controls [1]. |
Alias | DNPZ, 1,4-Dinitrosopiperazine |
Molecular Weight | 144.13 |
Formula | C4H8N4O2 |
Cas No. | 140-79-4 |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 3 mg/mL (20.81 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.